Syahru Agung Setiawan

5PUBLICATIONS
12CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 28, 2026
Adverse Prognostic Significance of Activation-Induced Cytidine Deaminase in Diffuse Large B-Cell Lymphoma Patients Treated With R-CHOP.

|May 13, 2023
NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation.

I-Chang Su, Yu-Kai Su, Syahru Agung Setiawan

|Mar 29, 2023
KDM5D Histone Demethylase Identifies Platinum-Tolerant Head and Neck Cancer Cells Vulnerable to Mitotic Catastrophe.

Tsung-Ming Chen, Chih-Ming Huang, Syahru Agung Setiawan

|Jul 27, 2022
Ubiquitin-Specific Protease 6 n-Terminal-like Protein (USP6NL) and the Epidermal Growth Factor Receptor (EGFR) Signaling Axis Regulates Ubiquitin-Mediated DNA Repair and Temozolomide-Resistance in Glioblastoma.

I-Chang Su, Yu-Kai Su, Hao-Yu Chuang

|Jul 09, 2022
Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells.

Tung-Yu Tiong, Pei-Wei Weng, Chun-Hua Wang

Pageof 1

Frequent Collaborators

4 joint publications

Chi-Tai Yeh

3 joint publications

Vijesh Kumar Yadav

2 joint publications

Chien-Min Lin

1 joint publications

Pei-Wei Weng